Folate Analog Metabolic Inhibitor [EPC]

298451 reported adverse events

Drugs of this class: METHOTREXATE PRALATREXATE

These side effects are most commonly reported by patients taking drugs of the Folate Analog Metabolic Inhibitor [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 51672
1 RHEUMATOID ARTHRITIS 26643
2 ARTHRALGIA 23536
3 PAIN 22394
4 FATIGUE 17633
5 NAUSEA 16298
6 OFF LABEL USE 15142
7 JOINT SWELLING 14022
8 HEADACHE 13574
9 INJECTION SITE PAIN 12822
See all common reactions for Folate Analog Metabolic Inhibitor [EPC]

Drugs of the Folate Analog Metabolic Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SWOLLEN JOINT COUNT INCREASED 289 0.8975
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1580 0.8876
2 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 253 0.8754
3 RHEUMATOID FACTOR POSITIVE 1631 0.7600
4 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 1239 0.7183
5 PEMPHIGUS 3206 0.6858
6 C-REACTIVE PROTEIN ABNORMAL 1912 0.6637
7 SYNOVITIS 5937 0.6286
8 RHEUMATIC FEVER 331 0.6018
9 GRANULOMA SKIN 322 0.5897
See all enriched reactions for Folate Analog Metabolic Inhibitor [EPC]